On 3 February, the American Bankers Association Banking Journal carried an article providing guidance and information about the use and uses of hemp. It explains briefly the historic uses of the product, saying that until late 2018, industrial hemp was covered by the restrictions that applied to marijuana and other narcotics under the federal Controlled Substances Act, even though industrial hemp lacks the same chemical compounds that provide the “high” produced from ingesting marijuana. However, the Farm Bill in 2018 carved out a special exception from the Controlled Substances Act for certain strains of hemp. And, as a result, hemp can be legally grown in the US, as long as certain conditions are met. For bankers, it says, those conditions are the critical factor. For example, for a plant to qualify as hemp it must have less than 0.3% concentration of tetrahydrocannabinol, or THC. The article also mentions one derivative that has generated a great deal of interest: CBD, or cannabidiol, which is subject to oversight by the Food and Drug Administration (FDA).